Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.01
+0.10 (+0.40%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
45,048,526
Open
24.82
Bid (Size)
25.03 (5,100)
Ask (Size)
25.08 (100)
Prev. Close
24.91
Today's Range
24.67 - 25.18
52wk Range
23.11 - 28.75
Shares Outstanding
5,606,688,356
Dividend Yield
6.88%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?
↗
Today 15:29 EDT
There is more to this stock than meets the eye.
Via
The Motley Fool
Topics
Intellectual Property
Regeneron Pharmaceuticals Q2 Earnings Call Highlights
↗
July 30, 2026
Regeneron Pharmaceuticals (NASDAQ:REGN) reported second-quarter revenue growth of 17% from a year earlier to $4.3 billion, supported by continued strength in Dupixent, EYLEA HD and Libtayo. Non-GAAP...
Via
MarketBeat
Topics
ETFs
Earnings
Performance
YTD
-0.7%
-0.7%
1 Month
+3.9%
+3.9%
3 Month
-6.3%
-6.3%
6 Month
-4.2%
-4.2%
1 Year
+5.0%
+5.0%
More News
Read More
Regency Centers Q2 Earnings Call Highlights
↗
July 30, 2026
Via
MarketBeat
Topics
ETFs
Earnings
Pfizer Prepares Global Regulatory Litfulo Filings Following Skin Pigment Improvements In Late-Stage Trials
↗
July 30, 2026
Via
Benzinga
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
July 30, 2026
From
Pfizer Inc.
Via
Business Wire
What Health Experts Want You to Know About Pneumococcal Pneumonia
July 30, 2026
Via
StatePoint Media
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
July 29, 2026
From
Pfizer Inc.
Via
Business Wire
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
↗
July 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
Global Oral Contraceptive Drugs Market Growing at 7.3% CAGR Through 2034
↗
July 29, 2026
Via
Talk Markets
GOP Congressman Slams JD Vance's Silence Over CDC's $1.24 Billion Pfizer COVID Vaccine Contracts: 'Why Isn’t He Speaking Out'
↗
July 27, 2026
Via
Benzinga
Topics
Government
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS)
July 26, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Absurdly Cheap Dividend Stocks to Buy Before August
↗
July 26, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.
↗
July 25, 2026
Via
The Motley Fool
3 Healthcare Stocks We Keep Off Our Radar
July 24, 2026
Via
StockStory
BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring
↗
July 23, 2026
Via
The Motley Fool
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
↗
July 23, 2026
Via
The Motley Fool
3 Healthcare Stocks with Competitive Advantages
July 23, 2026
Via
StockStory
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
July 22, 2026
From
Pfizer Inc.
Via
Business Wire
Want Income for Life? Here Are 3 Stocks to Buy Now and Never Sell.
↗
July 22, 2026
Via
The Motley Fool
Topics
Economy
Pfizer Suspends Popular Menopause Cream in India
↗
July 20, 2026
Via
Benzinga
Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?
↗
July 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Unpopular Stocks We’re Skeptical Of
July 20, 2026
Via
StockStory
1 Stock Under $50 to Target This Week and 2 We Question
July 20, 2026
Via
StockStory
Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now
↗
July 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?
↗
July 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.01
When was Pfizer last traded?
The last trade of Pfizer was at 07/31/26 04:10 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 140.22B
How many shares of Pfizer are outstanding?
Pfizer has 140B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.